American Diabetes Association and IDF to Hold Symposium Highlighting Translational Research in Diabetes

ALEXANDRIA, Va., Dec. 1, 2015 /PRNewswire-USNewswire/ -- The American Diabetes Association® and the International Diabetes Federation (IDF) will hold a joint symposium on translational research and publish a series of new studies as part of the upcoming IDF World Diabetes Congress in Vancouver, Nov. 30–Dec. 4. The studies will be published online in Diabetes Care on December 1, to coincide with their presentation at the symposium. They will also be published in a special section of the January online and print editions of Diabetes Care, which will be released December 23.

Translational research applies findings from basic science to improve human health and well being. That is, it takes the findings from basic research and "translates" them into medical practice. Of more than 230 studies submitted for publication, the editorial team at Diabetes Care selected six, all of which will be presented at the symposium and published concurrently in the journal.

"Our criteria for selecting the final papers included novelty, innovation and the requirement to present an advancement in the field," said William Cefalu, MD, editor in chief of Diabetes Care. "The presentations will include a wide range of timely and diverse topics, ranging from evaluating transplantation strategies in type 1 diabetes, to physical activity studies, assessing diabetes remission after metabolic surgery and an assessment of pregnancy outcomes in youth with type 2 diabetes—an ever-growing problem. Given the international focus of the meeting and the symposium, and the international reach of Diabetes Care, it is gratifying that the presentations are by investigators from diverse parts of the globe, including China, Japan, the United Kingdom, the United States, Italy, Sweden and Australia."

"The number of manuscripts submitted for consideration for this special symposium is remarkable, and demonstrates the great interest in better understanding and finding new treatment approaches for diabetes, a non-communicable disease scourge of our time," said Steven Kahn, MD, Professor of Medicine in the Division of Metabolism, Endocrinology and Nutrition at the VA Puget Sound Health Care System and University of Washington, Seattle, who led the committee responsible for the program in the Clinical and Basic Science Stream at the Congress. "I am delighted that the American Diabetes Association and the editors of Diabetes Care, the foremost journal on diabetes translation, saw this an important and timely opportunity to publish this cutting-edge science."

For more detailed information about the symposium and to see abstracts of the selected studies, please visit the congress session page. Copies of the full studies will be available online Dec. 1 on the Diabetes Care site.

The American Diabetes Association is leading the fight to Stop Diabetes® and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information and gives voice to those denied their rights because of diabetes. For the past 75 years, our mission has been to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (800-342-2383) or visit diabetes.org. Information from both these sources is available in English and Spanish.